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Mice deficient for p66shcA represent an animal model to link oxidative stress and aging. p66shcA is implicated in
oxidative stress response and mitogenic signaling. Phosphorylation of p66shcA on Ser36 is critical for its function in
oxidative stress response. Here we report the identification of ERK as the kinase phosphorylating p66shcA on Ser36.
Activation of ERKs was necessary and sufficient for Ser36 phosphorylation. p66shcA interacted with ERK and was
demonstrated to be a substrate for ERK, with Ser36 being the major phosphorylation site. Furthermore, in response to
H2O2, inhibition of ERK activation repressed p66shcA-dependent phosphorylation of FOXO3a and the down-regulation
of its target gene p27kip1. Down-regulation of p27 might promote cell survival, as p27 played a proapoptotic role in
oxidative stress response. As a feedback regulation, Ser36 phosphorylated p66shcA attenuated H2O2-induced ERK
activation, whereas p52/46shcA facilitated ERK activation, which required tyrosine phosphorylation of CH1 domain.
p66shcA formed a complex with p52/46ShcA, which may provide a platform for efficient signal propagation. Taken
together, the data suggest there exists an interplay between ERK and ShcA proteins, which modulates the expression of
p27 and cell response to oxidative stress.
INTRODUCTION
Reactive oxygen species (ROS) are implicated in the patho-
genesis of degenerative diseases and in the process of aging
(Finkel and Holbrook, 2000; Droge, 2002). They are pro-
duced upon exposure to -ray or UV light, during oxidative
phosphorylation in mitochondria, or during inflammation
by macrophages, and cause damage to DNA, proteins, and
lipids, leading to cell death in the form of necrosis (high
dosage) or apoptosis (low dosage). A connection between
oxidative stress and aging has been established in Drosophila
and Caenorhabditis elegans (Finkel and Holbrook, 2000).
DAF-16 in C. elegans, encoding the forkhead related tran-
scription factor (FOXO3a/FKHRL1 in mammals), promotes
longevity in response to reduced insulin/IGF-1 signaling
(Kenyon et al., 1993). An analogous example in mammals is
the p66shcA knockout mice. Deletion of p66shcA from
mouse genome by gene targeting renders the mice resistant
to oxidative stress, and a 30% increase in average lifespan of
the mice was observed. Mouse embryonic fibroblasts (MEFs)
isolated from these mice are also resistant to the cytotoxic
effects of H2O2 (Migliaccio et al., 1999). Oxidative stress leads
to phosphorylation of p66shcA on Ser36. p66shcA carrying a
S36A mutation, when reintroduced back into p66shcA null
MEFs, could not correct the resistance of these cells to oxi-
dative stress, suggesting that Ser36 phosphorylation is crit-
ical for the proapoptotic activity of p66shcA in response to
oxidative stress (Migliaccio et al., 1999). Recent studies have
suggested a link between p66shcA and FOXO3a. In
p66shcA-deficient MEFs, H2O2-induced phosphorylation/
inactivation of FOXO3a is inhibited, correlated with in-
creased activity of FOXO3a and up-regulation of target
genes involved in free radical scavenging and oxidative
stress resistance. Hence, the proapoptotic activity of
p66shcA in response to oxidative stress might be mediated
by FOXO3a (Nemoto and Finkel, 2002). Furthermore, phos-
phorylation of Ser36 on p66shcA was found to be critical for
FOXO3a phosphorylation (Nemoto and Finkel, 2002).
Hence, Ser36 phosphorylation is essential for p66shcA func-
tion in oxidative stress responses, in which Akt/FOXO3a
play critical roles. However, the kinase responsible for this
phosphorylation has not been identified.
p66shcA, p52shcA, and p46shcA constitute the ShcA fam-
ily (reviewed in Luzi et al., 2000; Ravichandran, 2001). All
three isoforms contain a phospho-tyrosine binding domain
(PTB), a collagen homology domain 1 (CH1), and a Src
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homology 2 domain (SH2), whereas p66shcA has a unique
collagen homology domain 2 (CH2) at the N terminus in
which Ser36 is located (Luzi et al., 2000). Working as adaptor
proteins, p52 and p46 transmit signals from receptor ty-
rosine kinases (RTK) to the RAS-MAPK pathway (reviewed
in Luzi et al., 2000). Their SH2 and PTB domains are respon-
sible for binding to the phosphorylated tyrosine residues of
activated RTK, which subsequently phosphorylates the CH1
domain on tyrosine residues Y239/240 and/or Y317. Phos-
phorylated ShcA proteins form a complex with Grb2, which
constitutively interacts with Sos (Rozakis-Adcock et al.,
1992). Recruitment of Grb2-Sos complex to the plasma mem-
brane by p46/52 shcA leads to activation of Ras-ERKs path-
way, and this promotes cell proliferation/transformation
and cell survival (Ullrich and Schlessinger, 1990; Schless-
inger, 2000). p66shcA is also phosphorylated after growth
factor stimulation, but it competes with p52shcA for Grb2
binding (Migliaccio et al., 1997). Overexpression of p66shcA
markedly inhibits activation of ERK after epidermal growth
factor (EGF) stimulation in Chinese hamster ovary cells
(Okada et al., 1997). Thus p66shcA and p52/46shcA have
distinct functions in response to growth factor stimulation.
Although p66shcA plays an important role in cell response
to oxidative stress, the roles for p52shcA and p42shcA have
not been explored.
In addition to their toxic and proapoptotic roles, ROS have
been recently recognized as molecules with important phys-
iological functions including acting as an oxygen sensor in
the regulation of erythropoietin production, maintenance of
redox homeostasis, and enhancement of cell signaling and
amplification of cell responses to growth factors and anti-
gens (Reth, 2002; Mikkelsen and Wardman, 2003). In some
cases, ROS appear to function as second messengers in cell
signaling, being produced in response to external stimuli
and subsequently used for signal amplification (reviewed in
Droge, 2002; Finkel, 2003). ROS can directly activate signal-
ing molecules via modification, or indirectly activate signal-
ing cascades by inhibiting protein tyrosine phosphatases.
Yet the molecular mechanisms by which ROS function as a
mitogen are still elusive. In an attempt to identify the kinase
responsible for ShcA66 Ser36 phosphorylation upon oxida-
tive stress, we found that 1) ERKs were responsible for
H2O2-induced Ser36 phosphorylation of p66shcA; 2) ERKs
acted upstream of p66shcA-Akt -FOXO3a pathway, which
was delineated from studies on p66shcA/ cells (Nemoto
and Finkel, 2002); 3) one major target of ERK-ShcA66-
FOXO3a pathway was p27, whose down-regulation by
H2O2 required Ser36 phosphorylation of p66shcA; 4) p27
participated in cell response to oxidative stress; 5) H2O2-
induced ERK activation was facilitated by p52/46shcA but
hindered by p66shcA, and that H2O2 promoted the interac-
tion between p66shcA and p52/46shcA. This suggests the
existence of a negative feedback loop for regulation of ERK
activation. The interaction between ShcA proteins may pro-




Hydrogen peroxide was obtained from Acros Organics (Pittsburgh, PA).
U0126 and wortmannin were purchased from Calbiochem (La Jolla, CA). JNK
inhibitors were obtained from Calbiochem ((L)-form) and Alexis Biochemicals
((D)-form; San Diego, CA). Antibodies against active ERK, active p38 MAPK,
active JNK, active Akt, Thr32 phosphorylated FOXO3a, Ser256 phosphory-
lated FOXO1, and ERK were obtained from Cell Signaling (Beverly, MA).
Antibodies against p27, p21, and horseradish peroxidase–conjugated phos-
pho-tyrosine antibodies were obtained from BD Biosciences (San Diego, CA).
Antibodies against HA tag, Myc tag, and ShcA were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA). Antibodies against Ser36 phosphory-
lated ShcA were obtained from Calbiochem.
Cell Culture
MEFs were prepared following a standard protocol and these primary MEFs,
NIH3T3, and immortalized Jnk1/Jnk2/, ShcA/, ShcA/, Src/, and
Src/ MEFs were cultured in DMEM (Life Technologies, Rockville, MD)
containing 10% fetal calf serum (HyClone, Logan, UT) supplemented with
glutamine and penicillin/streptomycin, and COS7 cells were cultured in
DMEM containing 10% bovine calf serum (HyClone) supplemented with
glutamine and penicillin/streptomycin. To generate ShcA/ cells expressing
p66shcA or p66shcA(S36A), ShcA/ MEFs were transfected with constructs
expressing these proteins or the empty vector, respectively, selected against
puromycin (expressed by these constructs) for 2 wk. The expression of
p66shcA or p66shcA(S36A) was analyzed by Western blot in comparison to
ShcA/ MEFs.
Mutagenesis
Point mutations of ShcA were generated using a site-directed mutagenesis Kit
from Invitrogen (Carlsbad, CA), following the manufacturer’s protocol. Trun-
cations of ShcA were synthesized by PCR and subsequently cloned into the
expression vector pcDNA3.1. All the expression constructs were sequenced to
verify the mutations.
Immunoprecipitation, Western Blot, and
Immunohistochemistry
Cells were subcultured the day before and then treated with H2O2 for various
durations of time. To test the effects of the kinase inhibitors, specific inhibitors
were added to the cell cultures 1 h before the addition of H2O2. Cells were
washed with phosphate-buffered saline (PBS) and lysed in TNEN buffer
containing 50 mM Tris, pH 7.5, 100 mM KCl, 1 mM EDTA, 0.5% NP-40, 1 mM
phenylmethylsulfonyl fluoride (PMSF), 1 mM sodium orthorvanadate, 10 mM
NaF, 1 mM beta-glycerol phosphate, and 10 g/ml each of aprotonin and
leupeptin (Li et al., 2002). Protein concentrations were determined by Bio-Rad
protein quantitation assays (Richmond, CA). Equal amounts of protein (20
g) were fractionated by electrophoresis on SDS-PAGE gels, transferred onto
a nitrocellulose membrane (Millipore, Billerica, MA), probed with primary
and secondary antibodies, and visualized using an ECL kit (Amersham,
Piscataway, NJ). For immunoprecipitation (IP), antibodies against HA, myc,
ShcA, or ERKs were added to the cell lysate (400 g) for overnight incubation,
followed by addition of protein A plus G agarose beads for two more hours.
The beads were washed with TNEN buffer three times and once with PBS.
The immunoprecipitated proteins were released from the beads by boiling in
1 sample buffer for 5 min and subsequently analyzing by Western blot. Total
cell lysate (20 g) was run next to the IP samples to assess the portions of
proteins that were coprecipitated.
COS7 cells grown on coverslips were transfected with lipofectamine (Life
Technologies, Gaithersburg, MD). After 24 h, the cells were permeabilized
with methanol at 20°C for 3 min, washed three times with PBS containing
10% bovine calf serum, and incubated with the primary antibodies for 1 h at
room temperature. 9E10 was used to detect p66shcA (myc-tagged), and
polyclonal anti-ERK antibodies were used to detect ERKs. After interaction
with the primary antibody, the slides were washed three times with PBS
containing 10% bovine calf serum and then incubated with secondary anti-
mouse antibodies conjugated with Texas Red (Sigma, St. Louis, MO) and
anti-rabbit antibodies conjugated with FITC for 1 h at room temperature. The
slides were then rinsed with PBS and examined under a confocal microscope.
GST Fusion Protein Preparation
ShcA 46, ShcA52, ShcA66, and ShcA66(S36A) were each cloned into the pGEX
vector that was then transformed into BL21 cells. The bacteria were cultured
in 40 ml LB with 100 g/ml ampicillin at 37°C overnight with vigorous
shaking. On the second day, the cultures were used to inoculate 800 ml LB
medium with 100 g/ml ampicillin and shaken at 37°C until OD600 reached
1.0. IPTG was added to the culture to a final concentration of 0.15 mM. The
cells were further cultured at 30°C for 6 h, harvested, resuspended in MTPBS
buffer (150 mM NaCl, 16 mM Na2HPO4, 5 mM NaH2PO4, 1 mg/ml lysozyme,
1% Trition X-100, 0.05 mM PMSF, 1 mM dithiothreitol [DTT]), and sonicated
30 s for five times. Insoluble debris was removed by centrifugation at 3000g
for 30 min at 4°C. The cell lysates were combined with 50% slurry of gluta-
thione-agarose resin and then incubated for 30 min at 4°C. The resin was
washed with PBS five times. Bound GST fusion protein was eluted using
elution buffer (10 mM reduced glutathione, 50 mM Tris-HCl, pH 8.0).
In Vitro Kinase Assay for ERK
ERK1 (HA-tagged) was expressed in COS7 cells, and one set of cells was
treated with 0.5 mM H2O2 for 10 min. The other set was left untreated. ERK1
was immunoprecipitated from either set of cells using anti-HA antibody and
protein A-agarose beads. Purified GST-ShcA66 or GST-ShcA66(S36A) protein
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(3 g each) was mixed with protein A beads bound-ERK in 30 l kinase assay
buffer (25 mM Tris-HCl, pH 7.4, 5 mM MgCl2, 0.5 mM EGTA, 1 mM DTT, 20
M ATP, 20 Ci [-32P]ATP, 0.1 mM sodium orthovanadate) and incubated
at room temperature for 20 min. The reaction was terminated by addition of
5 SDS-PAGE sample buffer and boiling at 100°C for 5 min. Proteins were
analyzed by SDS-PAGE, and the phosphorylated form of GST-ShcA66 or
GST-ShcA66(S36A) was detected by auto-radiography.
RT-PCR
To determine the mRNA levels of p27, we isolated total RNA from cells using
Trizol. Reverse transcription reactions were carried out with 5 g of total
RNA following the standard protocol supplied with the reverse transcriptase
(Roche, Indianapolis, IN). The resulting cDNA was used for PCR and actin
was used as a control. The primers used are: 5-GTCAAACGTGAGAGT-
GTCTAAC-3; 5-GTTTACGTCTGGCGTCGAAGGC-3. The primers for actin
were as follows: forward, 5-AGATGTGGATCAGCAAGCAG-3; reverse, 5-
GCGCAAGTTAGGTTTTGTCA-3.
Cell Cycle and Cell Viability Analysis
Cells were serum-starved overnight, treated with increasing concentrations of
H2O2 for 24 h, trypsinized and fixed in 70% ethanol, and washed and
analyzed by flow cytometry after PI staining. To measure cell death rates, cells
were cultured in 96-well plates at 1  104/well, serum-starved for 24 h, and
then treated with different concentrations of H2O2 for 4 h. Cell proliferation
reagent WST-1 (Roche) was added to each well, and the cells were incubated
for 1 more hour at 37°C. The absorbance was measured against a background
control by microplates (ELISA) reader at 430 nm. The reference wavelength is
650 nm. Trypan blue exclusion assays were used to confirm the results
obtained from this quantitative assay.
RESULTS
H2O2-induced Ser36 Phosphorylation of p66shcA
Phosphorylation of p66shcA at Ser/Thr residues has been
reported in cells exposed to H2O2, UV, taxol, or endothelin
(Yang and Horwitz, 2000; Le et al., 2001; Foschi et al., 2001).
In these studies, a retarded migration of p66shcA on a
Western blot was used as an indicator for Ser/Thr phos-
phorylation. It was discovered that H2O2-induced p66shcA
phosphorylation occurred on Ser36 (Migliaccio et al., 1999).
Because p66shcA can be phosphorylated at multiple sites:
Ser36, Ser138, and tyrosine residues on the CH1 domain
(Faisal et al., 2002), migration retardation may not necessar-
ily represent phosphorylation at Ser36 (Supplementary Data
S1). Instead we used a recently developed monoclonal anti-
body that specifically recognizes Ser36 phosphorylated
p66shcA throughout our studies (Figure 1A). A dosage
course study showed that as little as 0.2 mM of H2O2 could
induce Ser36 phosphorylation in serum-starved cells (Figure
1B). Ser36 phosphorylation reached the maximal level at 0.5
mM and then declined with higher doses of H2O2. A time
course study revealed that Ser36 phosphorylation (close to
the maximal level) occurred at 10 min after stimulation with
0.5 mM H2O2 (Figure 1C).
ERK1/2 Activation Was Necessary and Sufficient for
Phosphorylation of p66shcA on Ser36
To identify the kinase responsible for p66shcA phosphory-
lation on Ser36, which is critical for its function in response
to H2O2, we first tested MAPKs because JNK has been found
necessary for Ser/Thr phosphorylation of p66shcA in hu-
man neuroblastoma cell line in response to UV irradiation
(Le et al., 2001), and ERK has been implicated in p66shcA
phosphorylation in response to endothelin or taxol (Yang
and Horwitz, 2000; Foschi et al., 2001). As expected, JNKs
were activated upon H2O2 treatment in NIH3T3 cells (un-
published data). Yet pretreatment with 20 M of JNK spe-
cific inhibitor (L- or D-form) for 1 h did not affect H2O2-
induced Ser36 phosphorylation (unpublished data). The
JNK inhibitor, at 20 M, is sufficient to inhibit JNK activity
(Le et al., 2001). Furthermore, immortalized MEFs derived
from mice deficient for both JNK1 and JNK2 was compared
with NIH3T3 cells and we found that phosphorylation of
p66shcA on Ser36 was not significantly inhibited in the
absence of JNK1/2 (Figure 2A). Because JNK3 is not ex-
pressed in MEFs (Tournier et al., 2000), we conclude that
activation of JNKs is not an absolute requirement for H2O2-
induced phosphorylation of Ser36. We observed that the
knockout cells showed a slight increase in the basal level of
phosphorylated p66shcA. This may reflect a compensation
mechanism occurred to cells deficient for all three JNKs, e.g.,
inactivation of phosphatases involved in terminating JNK
signaling. Similarly, inhibition of p38 MAPK activation by
SB25083 showed no effect on Ser36 phosphorylation (unpub-
lished data).
We next tested whether ERKs, which were also activated
by H2O2 (Figure 2B), played a role in phosphorylation of
p66shcA on Ser36 in response to oxidative stress. We used a
widely used inhibitor U0126 to inhibit MEK1, a kinase that
directly phosphorylates and activates ERK1/2. We found
that Ser36 phosphorylation of p66shcA was inhibited in a
dosage-dependent manner when cells were pretreated with
U0126 (Figure 2C). ERK1/2 activation was indeed sup-
pressed by the inhibitor in a dosage-dependent manner,
suggesting that ERK1/2 activation was required for Ser36
phosphorylation.
To further confirm this conclusion, a constitutively active
form of MEK1 was coexpressed with p66shcA and phos-
phorylation of Ser36 was tested on immunoprecipitated
p66shcA (Mansour et al., 1994). It was found that activated
MEK1 led to Ser36 phosphorylation even without H2O2
treatment and to much higher levels (Figure 2D), suggesting
that ERK activation was sufficient for Ser36 phosphoryla-
tion.
To demonstrate that p66shcA is a substrate for ERKs, an in
vitro kinase assay was carried out. p66shcA was fused to
GST and the fusion protein was expressed and purified. A
mutant GST-p66shcA, Ser36 to Ala (S36A), was also gener-
ated by site-directed mutagenesis, expressed in bacteria, and
Figure 1. H2O2 treatment induced phosphorylation of Ser36 of
p66shcA. (A) Ser36 phosphorylation can be specifically recognized
by the anti-phospho-Ser36 antibodies. NIH3T3 cells were trans-
fected with constructs expressing p66shcA or mutant p66shcA
(S36A), serum-starved, and then stimulated with H2O2 for 10 min.
Normal and mutant p66shcA proteins were immunoprecipitated
and analyzed by Western blot using specific antibodies. (B) Dosage
studies of phosphorylation of p66shcA on Ser36 and tyrosine phos-
phorylation. NIH3T3 cells were treated with increasing concentra-
tions of H2O2 for 10 min, collected, and lysed. p66shcA proteins
were immunoprecipitated with anti-p66shcA antibodies. Antibod-
ies against Ser36 phosphorylated p66shcA were used to detect Ser36
phosphorylation. (C) Cells were treated with 0.5 mM H2O2 for
different periods of time. p66shcA was immunoprecipitated and
Ser36 phosphorylation was determined as in B.
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purified. ERK1 was expressed in COS7 cells and immuno-
precipitated. The kinase assay was carried out using
p66shcA or p66shcA (S36A) as a substrate. It was observed
that activated ERK1 but not activated MEK1, which were
isolated from H2O2-treated cells, was able to phosphorylate
p66shcA (Figure 2E). Phosphorylation of p66shcA (S36A)
was considerably less, indicating that Ser36 was a major site
for ERK1. Furthermore, Western blot analysis with the spe-
cific anti-phospho-p66shcA antibodies confirmed that the
Ser36 was indeed phosphorylated in the in vitro assay (Fig-
ure 2F). In the same settings, ERK5, another member of the
MAPK family that can be activated by oxidative stress (Abe
et al., 1996), failed to phosphorylate p66shcA at Ser36 (Figure
2F). The results indicate that p66shcA is a bona fide substrate
for ERK1/2, but not for ERK5. In the p66shcA protein se-
quence, Ser36 is followed by Pro37, constituting a MAP
kinase recognition motif (Kolch, 2000; Sharrocks et al., 2000).
ERK1 Formed a Complex with p66shcA
Having shown that in response to H2O2 treatment, ERK1/2
phosphorylated p66shcA on Ser36, we next questioned
whether ERKs physically interact with p66shcA. To test
whether ERK1 and p66shcA interact, we first used COS7
cells to do co-IP assays. COS7 cells were transfected with
constructs expressing either HA-tagged ERK1, or ERK1 and
myc-tagged p66shcA. Ectopically expressed p66shcA, along
with its associated proteins, was precipitated with anti-myc
antibodies, and fractionated onto an 8% SDS-PAGE gel.
ERK1 was detected with anti-HA antibodies. We found that
ERK1 (20% of expressed ERKs) coprecipitated with
p66shcA, but was not pulled down when p66shcA was not
expressed (Figure 3A). Treatment of COS7 cells with H2O2
for 10 min did not increase the formation of ShcA-ERK1
complex. Reciprocally, COS7 cells were transfected with
Figure 2. Activation of ERK, but not JNKs, was sufficient and required for phosphorylation of p66shcA on Ser36. (A) H2O2-induced p66shcA
phosphorylation on Ser36 was not reduced by JNK1/JNK2 deficiency. NIH3T3 and immortalized MEFs isolated from Jnk1/ Jnk2/ mice
were starved and treated with 0.5 mM H2O2 for 5 or 10 min. Endogenous p66shcA was immunoprecipitated, and its phosphorylation on Ser36
was analyzed by Western blot. (B) H2O2 treatment led to ERK activation in a dosage-dependent manner. Cells were treated with increasing
concentrations of H2O2 for 10 min, and ERK activation was determined by Western blot using antibodies specifically recognizing activated
ERKs. (C) Inhibition of ERK MAPKs with a specific inhibitor U0126 suppressed Ser36 phosphorylation. NIH3T3 cells were pretreated with
U0126 (5, 10, 15 M) for 1 h before H2O2 was added. Phosphorylation of p66shcA on Ser36 was determined by Western blot analysis. (D)
Coexpression of the constitutively active MEK1 (MEK1) led to massive phosphorylation of p66shcA on Ser36. The mutant form of MEK1
and p66shcA were used to transfect NIH3T3 cells, which were serum-starved for 20 h and stimulated with H2O2 for 10 min. p66shcA was
immunoprecipitated and its Ser36 phosphorylation was determined by Western blot. (E) ERK1 was able to phosphorylate p66shcA in vitro
in a Ser36-dependent manner. ERK1 and MEK1 were immunoprecipitated from COS7 cells treated or untreated with H2O2 and in vitro
kinase assays were performed using GST-p66shcA and mutant GST-p66shcA(S36A) as the substrate. (F) ERK1, but not ERK5, was able to
phosphorylate p66shcA at Ser36. The experiment was carried out as in E, except that cold ATP was used and the phosphorylation was
analyzed by Western blot using the specific anti-phospho-p66shcA antibodies.
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DNA expressing p66shcA, or DNA expressing p66shcA and
ERK1. ERK1, along with its associated proteins, was precip-
itated from cell lysate with anti-HA antibodies and fraction-
ated on 8% SDS-PAGE gel. p66shcA was detected with
anti-myc antibodies by Western blot. p66shcA (15% of the
expressed p66shcA) was pulled down from the lysate by
ERK1, but was not pulled down with anti-HA antibodies
when ERK1 was not coexpressed (Figure 3B). Treatment of
COS7 cells with H2O2 for 10 min slightly increased forma-
tion of ShcA-ERK1 complex. Together these results indicate
that p66shcA interacts with ERK1 and formation of a com-
plex may facilitate p66shcA phosphorylation by ERK1. Fur-
thermore, co-IP assays confirmed the interaction between
endogenous p66shcA and ERKs (Figure 3C), as p66shcA was
precipitated by anti-ERK antibodies conjugated to agarose
beads. Similarly, ERK1/2 could be precipitated with anti-
p66shcA antibodies (Figure 3D). The fact that H2O2 was not
found to increase ERK-p66ShcA complex formation consis-
tently could be due to technical difficulties, especially with
proteins like p66shcA that is expressed at very low levels
and have many interacting partners (see below). Alterna-
tively, it could be that the increase in complex formation is
mediated by phosphorylation, which is removed quickly in
the signaling cascade. For example, tyrosine phosphoryla-
tion of ShcA proteins reached the maximal level after 5 min
of stimulation with H2O2 and started to decline after 10 min
(see below).
Alignment of ShcA against the consensus MAPK docking
domains revealed that ShcA proteins do have a docking site
in the SH2 domain (479 LQGEPWFHGKLSRREAEALLQL
500; residues in bold are highly conserved). Although no
canonical ERK binding site (Phe-Xaa-Phe-Pro) was found,
the CH2 domain of p66shcA did contain a Phe-Phe-Promotif
(24 aa downstream of Ser36). Together with Ser36-Pro37, it
may constitute an ERK docking site (reviewed in Kolch,
2000; Sharrocks et al., 2000). To determine whether this pu-
tative docking site was required for the interaction between
ERK and p66shcA, we generated two point mutations in the
docking sites of p66shcA (Arg491Arg492 to AlaAla and
ArgArg to GluGlu) and tested their influence on ERK-
p66shcA interaction in co-IP experiments. It was found that
these two mutants could still bind to ERK in a manner
similar to that of the wild-type p66shcA (Figure 3E). Fur-
thermore, we found that neither p52 nor p46shcA, which
contains the docking site, was able to interact with ERK in
the co-IP experiments, suggesting that this docking site is
not important in this interaction (Figure 3F). Rather, these
Figure 3. Interaction between ERK1 and
p66shcA. p66shcA (myc tagged) and ERK1
(HA tagged) were coexpressed in COS7 cells
and co-IP experiments were carried out. (A)
p66shcA and associated proteins were pre-
cipitated with anti-myc antibody, and ERK1
was detected with anti-HA. Cells transfected
with DNA expressing ERK1 alone were used
as control. (B) ERK1 and associated proteins
were precipitated with anti-HA, and p66shcA
was detected with anti-myc. Cells transfected
with p66shcA alone were used as a control.
(C) Co-IP of endogenous p66shcA with ERK.
Cell lysates were incubated with anti-ERK1
antibodies conjugated with agarose beads
overnight, washed with lysis buffer, and an-
alyzed by Western blot using anti-p66shcA
antibodies. Rabbit IgG conjugated to agarose
beads was used as a control in the assays.
One twentieth of the cell lysate used for IP
experiment was loaded as a control. (D)
Co-IP of endogenous ERK with p66shcA. Cell
lysates were incubated with anti-p66shcA an-
tibodies and protein A beads, washed with
lysis buffer, and analyzed by Western blot
using anti-ERK antibodies. Rabbit IgG was
used as a control in the assays. One twentieth
of the cell lysate used for IP experiment was
loaded as control. (E) Mutations of putative
docking sites of SH2 domain did not affect the
interaction between ERK and p66shcA. The
experiments were carried out as in B, except
that mutant p66shcA proteins were used as
well (RR to AA, p66RA; RR to EE, p66RE). (F)
p52shcA or p46shcA did not interact with
ERK1. The experiments were carried out as
described in B.
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results indicate that the CH2 domain of p66shcA plays an
essential role in this interaction.
We also tested whether ERK and p66shcA colocalize in
fibroblasts. COS7 cells were transfected with ERK1 and myc-
tagged p66shcA, starved for 20 h, stimulated with 0.5 mM
H2O2 for 10 min, and fixed and stained with anti-myc anti-
body and anti-ERK antibodies. It appears that these two
proteins colocalize in the cell, especially in the cytoplasmic
region (unpublished data). A proportion of the ERK1 was
also found in the nucleus, whereas no significant amount of
p66shcA was detected in the nucleus. H2O2 treatment did
not induce nuclear accumulation/translocation of ERK1.
The results indicate that p66shcA is a cytoplasmic substrate
for ERKs.
Inhibition of ERKs Diminished FOXO3a Phosphorylation
p66shcA plays a proapoptotic role in response to oxidative
stress, by modulating FOXO3a activity, a member of fork-
head-related transcription factors (Nemoto and Finkel,
2002). The activity of FOXO3a is dependent on its Thr32
phosphorylation status: the nonphosphorylated form can
enter the nucleus and is transcriptionally active, whereas the
phosphorylated form remains in the cytoplasm. Further-
more, phosphorylation of FOXO proteins can also affect
their DNA-binding activities and transactivation activities
(Van Der Heide et al., 2004). We did observe Akt activation,
FOXO3a phosphorylation at Thr32, and a significant trans-
location of FOXO3a from the nucleus to the cytoplasm in
response to H2O2 (Figure 4A and Supplementary Data S2). It
was also found that the majority of the FOXO3a proteins
were already in the cytoplasm, likely due to the fact that the
cells were serum-starved (Supplementary Data S2). None-
theless, these results indicate that H2O2 treatment could
inactivate FOXO3a via cytoplasm sequestration. Thr32 phos-
phorylation is a function of Akt kinase and requires Ser36
phosphorylation of p66shcA in response to oxidative stress,
because H2O2-induced Thr32 phosphorylation of FOXO3a is
dramatically reduced p66shcA-deficient cells (Nemoto and
Finkel, 2002). Because ERK1/2 were upstream of p66shcA
and responsible for Ser36 phosphorylation, we predicted
that interference with ERK1/2 would also affect the Akt
activity and FOXO3a phosphorylation. As expected, H2O2-
induced activation of Akt1 was inhibited by U0126 in a
dosage-dependent manner, and so was phosphorylation of
FOXO3a on Thr32 (Figure 4B). These results further support
the conclusion that ERK1/2 act as positive regulators of
p66shcA in response to oxidative stress. Comparison of Akt
activation and p66shcA phosphorylation (Figure 1B vs. 4A)
revealed that p66shcA phosphorylation, but not Akt activa-
tion, declined in the presence of a higher concentration of
H2O2. Activation of Akt at high concentrations of H2O2 may
be mediated by a pathway independent of p66shcA, e.g.,
phosphoinositide-dependent kinase 1 (PDK1). It has been
reported that PDK1 could be activated by H2O2 in fibro-
blasts via tyrosine phosphorylation, especially at higher con-
centrations (1.0 mM; Prasad et al., 2000). Furthermore,
inhibition of Akt activation by wortmannin abrogated the
FOXO3a phosphorylation (unpublished data), confirming
the observation that Akt is the major kinase responsible for
FOXO phosphorylation in response to oxidative stress.
Figure 4. Phosphorylation of FOXO3a on Thr32 induced by H2O2 involved ERKs activation. (A) H2O2 treatment led to Akt activation and
FOXO3a phosphorylation on Thr32. Cells were treated with increasing concentrations of H2O2 for 10 min. Akt activation and FOXO3a
phosphorylation were analyzed by Western blot using anti-activated Akt antibodies and anti-phospho-FOXO3a antibodies, respectively. (B)
Inhibition of ERK activation compromised H2O2-induced Akt activation and FOXO3a phosphorylation. NIH3T3 cells were pretreated with
different concentrations of U0126 before H2O2 was added. Activation of Akt and phosphorylation of FOXO3a were analyzed by Western blot
as described in Figure 3A. (C) Serum stimulation induced Ser36 phosphorylation required ERK activation. Cells were starved and pretreated
with U0126 for 1 h before serum was added. Endogenous p66shcA was immunoprecipitated and Ser36 phosphorylation was determined by
Western blot. (D) Serum-induced activation of AKT and FOXO3a phosphorylation were not affected by inhibition of ERKs activation. The
experiments were done as described in B, except that 10% serum was used to treat cells.
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We also analyzed another member of the forkhead family,
FOXO1, in response to H2O2 treatment. We found that phos-
phorylation of FOXO1 on Thr28 (corresponding to Thr32 of
FOXO3a, which can be recognized by the same antibody)
was barely detectable in presence of H2O2, suggesting that
Thr28 phosphorylation of FOXO1 may not be involved in
oxidative stress response (unpublished data). On the con-
trary, phosphorylation of Ser256 on FOXO1, also a function
of Akt, was strongly stimulated by H2O2. Inhibition of ERK
also diminished Ser256 phosphorylation in dosage-depen-
dent manner (unpublished data).
Serum Stimulation Led to p66shcA Phosphorylation on
Ser36 in an ERK-dependent Manner
Because serum stimulation also leads to ERK activation, we
tested whether it induces p66shcA phosphorylation on
Ser36. NIH3T3 cells were serum-starved for 20 h and there-
after stimulated with 10% serum for 10 min. Endogenous
p66shcA was immunoprecipitated, and its phosphorylation
on Ser36 was analyzed by Western blot with specific anti-
bodies. We found that serum greatly induced Ser36 phos-
phorylation, which was blocked by ERK inhibition (Figure
4C), suggesting that ERKs are also responsible for serum-
induced Ser36 phosphorylation. As expected, Akt activation
was also observed and so was the phosphorylation of
FOXO3a. However, inhibition of ERK activation showed no
effect on Akt activation or FOXO3a phosphorylation, sug-
gesting that the ERK-p66shcA-Akt pathway is not a main
pathway in serum-induced Akt activation (Figure 4D). The
results excluded the possibility that U0126 may somehow
inhibit Akt activation in an unspecific manner.
H2O2 Treatment Down-regulated FOXO Target Gene p27
FOXO3a controls cell cycle, cell death, and oxidative stress
response through transactivating different sets of genes
(Tran et al., 2003). Expression profiles of a couple of known
FOXO3a target genes such as MnSOD and catalase were
tested in response to H2O2 treatment (Kops et al., 2002). In
our experimental settings, MnSOD and catalase levels did
not show any significant change after H2O2 exposure. In-
stead, H2O2 exposure at 0.2–0.5 mM from 2 to 20 h was able
to reduce the protein levels of p27kip1 (Figure 5A and Sup-
plementary Data S3), a cyclin-dependent kinase inhibitor
and a target gene for FOXO3a (Dijkers et al., 2000; Medema
et al., 2000; Stahl et al., 2002), whereas p21 and cyclin D was
not affected (unpublished data). p27 has FOXO3a-binding
sites in its promoter region, and its expression requires
activation of FOXO3a (Tran et al., 2003). The reduction of p27
on H2O2 exposure could be a consequence of inactivation of
FOXO3a through the p66shcA-Akt pathway because it was
accompanied by a translocation of FOXO3a from the nucleus
to the cytoplasm (Supplementary Data S2). More interest-
ingly, inhibition of ERK activation, which also compromised
Akt activation and inactivation of FOXO3a, was able to
suppress the down-regulation of p27 (Figure 5A). RT-PCR
assays confirmed that H2O2 treatment down-regulated p27
mRNA levels in several cell types tested, including NIH3T3
and MEFs, and that inhibition of ERKs abolished the down-
regulation (Figure 5B). These results indicate that H2O2
treatment also leads to a decrease in the levels of a CDK
inhibitor and might facilitate the cellular events involving
p27 and that ERK activation negatively regulates p27 expres-
sion at the mRNA levels. More importantly, MEFs lacking
p66shcA did not show this down-regulation of p27 (Figure
5C), which was restored by reconstitution of p66shcA in the
knockout cells (Figure 5D). But the MEFs expressing
p66shcA (S36A) behaved like the knockout mutant (Figure
5D). These results indicate that p27 down-regulation is also
dependent on the phosphorylation of Ser36 in p66shcA,
similar to the activation of Akt and phosphorylation of
FOXO3a in response to H2O2 (Nemoto and Finkel, 2002).
Participation of p27 in Cell Responses to Oxidative Stress
What is the biological function of reduced expression of p27
in cell response to oxidative stress? The observation that
CDK inhibitor p27 was down-regulated in response to H2O2
and the fact that low doses of ROS have been reported to
have mitogenic effect (Reth, 2002; Mikkelsen and Wardman,
2003) prompted us to test whether H2O2 could support cell
proliferation in our experimental settings. Serum-starved
cells were treated with increasing concentrations of H2O2 for
20 h (or 2 h), and their cell cycle profiles were analyzed by
FACS analysis. Only a marginal increase was observed in
the percentage of cells in G2/M phase (unpublished data).
Bromodeoxyuridine (BrdU) incorporation assays did not re-
veal an increase in the BrdU-positive cells in the presence of
H2O2, suggesting that the mitogenic effect is minimal. One
interpretation for failure to detect a mitogenic effect for H2O2
is because H2O2 also has a proapoptotic effect. Therefore, the
cells have to balance life and death under this condition, and
the ultimate cellular response to H2O2 is apoptosis in the
experimental settings. In fact, p27 is suitable for such a role
because it not only regulates cell cycle progression but also
apoptosis (Coqueret, 2003). p27 can be proapoptotic or an-
tiapoptotic, depending on the cell types used and the factors
used for apoptosis induction (Katayose et al., 1997; Hiro-
mura et al., 1999; Dijkers et al., 2000). To study the role for
p27 in oxidative stress–induced apoptosis, MEFs were pre-
pared from p27-deficient and control wild-type mice. These
primary MEFs were challenged with different concentra-
tions of H2O2 for 5 h, and the cell death rates and cell
survival rates were measured by trypan blue exclusion
method and a cell proliferation/survival kit, respectively. It
was found that p27/ MEFs survived better than control
wild-type cells in both assays (Figure 5E, unpublished data
for trypan blue exclusion method). These results indicate
that p27 possesses a proapoptotic function in oxidative
stress response. Therefore, down-regulation of p27 by H2O2
might normally protect the cells against oxidative stress. A
similar role for p27 and FOXO3a has been found in cytokine-
mediated survival of hematopoietic cells (Dijkers et al.,
2000).
Tyrosine Phosphorylation of p52/46shcA and Their Role in
H2O2-induced ERK Activation
It is known that ShcA proteins regulate ERK activation in
response to growth factors. Having shown that ERK could
phosphorylate p66shcA in the presence of H2O2, we in-
tended to study whether ShcA proteins have an influence on
ERK activation in cell response to oxidative stress. During
the studies of Ser36 phosphorylation, it was found that H2O2
also induced tyrosine phosphorylation of p66shcA, as well
as p52 and p46shcA (Figure 6A). For all three isoforms,
tyrosine phosphorylation was detectable at 0.2 mM and
reached the maximal level at 1.0 mM H2O2. A time course
study revealed that tyrosine phosphorylation of p66shcA
occurred at 5 min after treatment with 0.5 mM H2O2 (Figure
6B), indicating that tyrosine phosphorylation precedes Ser36
phosphorylation (Figure 1C). Hence, H2O2 treatment leads
to successive phosphorylation of all three ShcA proteins on
tyrosine residues and of p66shcA on Ser36 in murine fibro-
blasts.
What is the function of ShcA tyrosine phosphorylation in
response to H2O2? We first tried to determine whether these
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phosphorylated residues are the same as those induced by
growth factors. Because the levels of phosphorylation of
ShcA isoforms are proportional to their protein levels, we
assume that the tyrosine residue(s) might be shared by three
ShcA isoforms and we used the p52shcA to identify the
tyrosine residues. NIH3T3 cells were transfected with con-
Figure 5. H2O2 treatment down-regulated expression of p27 and its role in oxidative stress response. (A) H2O2 treatment down-regulated
expression of p27 without affecting MnSOD. Cells were treated with 0.1–0.5 mM of H2O2 for 20 h. The levels of p27 were determined by
Western blot. Inhibition of ERKs was found to rescue down-regulation of p27. (B) RT-PCR experiments showed that H2O2 treatment
down-regulated expression of p27 at mRNA levels. Notice that the p27 is a negative image of the gel. The experiments were done as in A.
Total RNA was isolated from the cells and RT-PCR was performed using a commercial kit. (C) ShcA/ MEFs showed no down-regulation
of p27 in response to H2O2. ShcA/ and control MEFs were treated with different concentrations of H2O2 and the levels of p27 were
determined by Western blot analysis. Bottom panel: quantitation data. (D) Ser36 of p66shcA played an important role in down-regulation of
p27. ShcA/ MEFs expressing p66shcA, p66shcA(S36A), or empty vector (top panel) were treated with different concentrations of H2O2 and
the levels of p27 were determined by Western blot analysis. Bottom panel: quantitation data. (E) p27-deficient MEFs showed an improved
survival than control wild-type cells. Primary mutant and wild-type MEFs were challenged with different concentrations of H2O2 for 5 h, and
the cell survival rates were determined as described in Materials and Methods.
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Figure 6. H2O2-induced Y239/240/317 phosphorylation of p46/52shcA facilitated ERK activation. (A) Dosage studies of tyrosine phos-
phorylation of all three ShcA isoforms in response to H2O2 treatment. Cells were treated as described in Figure 1C. p66shcA and p52/46shcA
were precipitated with anti-p66shcA and anti-ShcA, respectively, and tyrosine phosphorylation was detected by Western blot using
anti-phospho-tyrosine antibodies. (B) Cells were treated with 0.5 mM H2O2 for different periods of time; all ShcA proteins were immuno-
precipitated using anti-ShcA antibodies and analyzed by Western blot using anti-phospho-tyrosine antibodies. (C) Point mutation analysis
to identify the tyrosine residues that was phosphorylated in the presence of H2O2. p52shcA carrying mutations of Y239/240F, Y317F, or
Y239/240/317F (Y3F) were expressed in NIH3T3 cells (with or without H2O2 treatment), and tyrosine phosphorylation was determined as
described in A. (D) p66shcA shared the phosphorylated tyrosine residues with p46shcA. NIH3T3 cells were transfected with p66shcA or
p66shcA (Y3F) for 24 h, serum-starved for overnight, and stimulated with H2O2 for 10 min. p66shcA proteins were immunoprecipitated and
the tyrosine phosphorylation was detected using anti-phospho-tyrosine antibodies. (E) ERK activation by H2O2 required tyrosine phosphor-
ylation of p52/46shcA. NIH3T3 cells were transfected with HA-tagged ERK1 and p52shcA, p52shcA(Y3F), or vector, serum-starved for 20 h,
stimulated with 0.5 mM H2O2 for 10 min. ERK1 was immunoprecipitated and its activation was determined by Western blot using antibodies
that specifically recognized activated ERK. The blot was stripped and reblotted with anti-HA antibodies. Western blot was carried out to
check the expression of ShcA and activation of ERK. (F) Quantitation data from three repeated experiments. (G) Activation of ERKs by H2O2
was diminished in ShcA/ MEFs. Mutant and control MEFS were treated H2O2 with for different periods of time and activation of ERKs
was determined by Western blot analysis. (H) Coexpression of p66shcA slightly inhibited ERK activation in a Ser36-dependent manner.
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structs expressing various fragments of p46shcA (HA
tagged) and stressed with H2O2 for 10 min. ShcA fragments
were immunoprecipitated with anti-HA antibodies and an-
alyzed by Western blot using anti-phospho-tyrosine anti-
bodies. We found that tyrosine phosphorylation only oc-
curred to CH1 (unpublished data), the domain for tyrosine
phosphorylation upon a variety of stimuli, e.g., platelet-
derived growth factor receptor (Y239/240) and Src kinase
(Y317; van der Geer et al., 1996; Blake et al., 2000). We then
made point mutations at Y239/240/F, Y317/F, and Y239/
240/317F by site-directed mutagenesis in p52shcA. NIH3T3
cells were transfected with DNA expressing the mutant
p52shcA and subsequently treated with H2O2 for 10 min.
Tyrosine phosphorylation of these proteins was analyzed by
Western blot using anti-phospho-tyrosine antibodies (Figure
6C). Neither Y239/240/F nor Y317/F mutations signifi-
cantly affected the phosphorylation, whereas triple muta-
tions completely abolished tyrosine phosphorylation, indi-
cating that all three sites were phosphorylated upon H2O2
treatment. We then swapped the triple mutations into
p66shcA and found that they were the only tyrosine resi-
dues phosphorylated by H2O2 treatment (Figure 6D). We
showed, for the first time, that H2O2 treatment led to phos-
phorylation of all three tyrosine residues in all three ShcA
isoforms. Although Src kinase and PDGFR could phosphor-
ylate these residues, we found that pretreated NIH3T3 with
inhibitors for Src, PDGFR, or a combination of the two did
not significantly affected H2O2-induced tyrosine phosphor-
ylation of ShcA proteins (unpublished data). Furthermore,
Src/ MEF cells showed normal tyrosine phosphorylation
of all three ShcA isoforms even in the presence of PDGFR
inhibitor (unpublished data), suggesting that neither Src nor
PDGFR is required for ShcA tyrosine phosphorylation or
that there exist functionally redundant tyrosine kinases in
the cell.
Tyrosine phosphorylation has been involved in growth
factor induced ERK activation. Like growth factors, H2O2
can activate ERK1/2 in a dosage-dependent manner (Rao,
1996). Similarly, we found that in NIH3T3 cells, 0.25 mM of
H2O2 could significantly activate ERK1/2 and this was ac-
companied by increased complex formation between ShcA
and Grb2 (unpublished data). It has been reported that Src
plays important roles in H2O2-induced ERK activation
(Aikawa et al., 1997). We tested this conclusion using the
Src/ and control MEFs and found that Src was not re-
quired for ERK activation (unpublished data), suggesting
that redundant kinases may indeed exist in the cell. The
results are in agreement with our finding that Src deficiency
did not alter ShcA tyrosine phosphorylation.
To determine whether tyrosine phosphorylation of ShcA
plays a role in ERK activation, NIH3T3 cells were trans-
fected with HA-tagged ERK1, in combination with p52shcA
or p52shcA (Y239/240/317F), serum-starved for 20 h, and
treated with 0.5 mM H2O2 for 10 min. ERK1 was immuno-
precipitated using polyclonal anti-HA antibodies, and acti-
vated ERK1 was detected with anti-phosphorylated ERK
antibodies by Western blot. Expression of normal p52shcA
was able to enhance activation of ERK1 in response to H2O2
(Figure 6, E and F). On the other hand, expression of the
mutant p52shcA (Y239/240/371F) failed to do so (Figure 6,
E and F), suggesting that tyrosine phosphorylation of ShcA
is necessary for activation of ERKs in response to H2O2. The
triple mutations (Y239/240/371F) should not affect the fold-
ing of ShcA proteins, because p66shcA carrying the triple
mutations was similarly phosphorylated at Ser36 upon
H2O2 treatment and that p66shcA carrying these mutations
still possessed its ability to physically interact with its part-
ner p52shcA (Supplementary Data S3 and S4). To further
confirm that ShcA proteins are involved in ERK activation in
response to H2O2, ShcA/ fibroblasts were challenged
with different concentrations of H2O2, and ERK activation
was assessed by Western blot analysis. It was found that
ShcA/ fibroblasts showed compromised ERK activation
(Figure 6G), although the basal level of activated ERKs was
slightly higher in the ShcA-deficient cells. A similar defect in
ERK activation in response to low concentrations of growth
factors has been reported in ShcA/ fibroblasts (Lai and
Pawson, 2000). Taken together, our data indicate that H2O2
treatment results in tyrosine phosphorylation of p52/
46shcA, which in turn facilitates H2O2-induced ERK activa-
tion.
Phosphorylation of Ser36 Played a Negative Role in
H2O2-induced ERK Activation
Having shown that ERK interacted with p66shcA and phos-
phorylated p66shcA on Ser36 and that p52/46shcA facili-
tated H2O2-induced ERK activation, we wanted to deter-
mine whether Ser36 phosphorylation of p66shcA played a
role in H2O2-induced ERK activation. NIH3T3 cells were
cotransfected with ERK1 and p66shcA or p66shcA (S36A),
serum-starved for 20 h, and stimulated with H2O2 for 10
min. ERK1 was precipitated with anti-HA antibodies conju-
gated to agarose beads, and its activation was determined by
Western blot analysis. Unlike p52/46shcA, which strongly
facilitate ERK activation, p66shcA was found to suppress
activation of ERK (Figure 6H), consistent with the findings
that p66shcA plays an inhibitory role in ERK activation
stimulated by EGF (Migliaccio et al., 1997; Okada et al., 1997).
Surprisingly, mutant p66shcA (S36A) was found to facilitate
ERK activation, although only to a mild extent (Figure 6H),
suggesting that the normal function of p66shcA is to nega-
tively regulate ERK activation and that phosphorylation of
Ser36 may play an important role. To confirm this conclu-
sion, we overexpressed p66shcA, or p66shcA(S36A) in COS7
cells, which were subjected to stimulation with 0.5 mM H2O2
for different periods of time and the activation of endoge-
nous ERKs were detected by Western blot. It was found that
p66shcA inhibited H2O2-induced ERK activation (Figure 6I),
whereas expression of S36A mutant led to a slightly en-
hanced activation of ERK1/2.
Complex Formation among ShcA Proteins
Having shown that H2O2-induced ERK activation could be
facilitated by p52/46shcA but hampered by p66shcA, we
wanted to study the molecular basis for their different ac-
tions. p66shcA contains an extra 110 amino acid CH2 do-
Figure 6 (cont). NIH3T3 cells were transfected with HA-tagged ERK1 and p66shcA, p66shcA(S36A), or vector, serum-starved for 20 h, and
stimulated with 0.5 mM H2O2 for 10 min. Different amounts of DNA expressing p66shcA (S36A) was used to transfect cells to test their effects
on ERK activation. ERK1 was immunoprecipitated and its activation was determined by Western blot using antibodies that only recognize
activated ERK. The blot was stripped and reblotted with anti-HA antibodies. Western blot was carried out to check the expression of ShcA.
(I) Time course study of inhibition of ERK activation by p66shcA. COS7 cells were transfected with empty vector or constructs expressing
p66shcA or p66shcA(S36A) for 24 h, serum-starved overnight, and stimulated with 0.5 mM H2O2 for different periods of time, and ERKs
activation was determined by Western blot analysis. Bottom panel: quantitation data showing the activation of ERK1 and ERK2 combined.
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main compared with p52shcA and is a minor isoform in
fibroblasts. We first used pulldown assays to test whether
they exist as complexes in the cell. A GST-p52shcA fusion
protein was made and used in pulldown experiments
against p46shcA expressed in COS7 cells. Although GST-
p52shcA was able to precipitate p46shcA, GST itself failed to
do so (Figure 7A). Similarly, GST-p46shcA was made and
used in pulldown experiments against p52shcA. COS7 cells
were transfected with p52shcA, which expressed both
p52shcA and p46shcA due to two different start codons
being used. We found that GST-p46 was able to precipitate
both p52shcA and p46shcA, suggesting that p52-p46 and
p46-p46 dimers may exist (Figure 7B). Similar experiments
were carried out using GST-p46shcA fusion protein to pre-
cipitate CH1, PTB, or SH2 domains alone, and it was found
that PTB and CH1 domains were able to bind p46shcA
(unpublished data), suggesting that those two domains are
involved in complex formation between ShcA proteins. Be-
cause p66shcA contains PTB and CH1 domains, we believe
that p66shcA could also form complexes with p52shcA or
p46shcA.
Interaction between p46 and p52 was confirmed by co-IP
experiments. We found that p52shcA was able to immuno-
precipitate coexpressed p46shcA, whereas p46 could not be
precipitated when p52 was not coexpressed (Figure 7C).
H2O2 treatment did not significantly promote p52-p46 inter-
action. Reciprocally, p46shcA was able to precipitate both
p52shcA and p46shcA (expressed from the same construct;
Figure 7D), and H2O2 treatment did not significantly en-
hance the complex formation. These results suggest that
ShcA proteins do interact in vivo.
As mentioned above, p66shcA and p52/46shcA play dis-
tinct roles in ERK activation induced by growth factors or
H2O2 (Figure 6 and Migliaccio et al., 1997). To test whether
p66shcA interact with p52 or p46, we transfected COS7 cells
with myc-tagged p66 and HA-tagged p52. One set was
stimulated with H2O2, whereas the other set was left un-
treated. p66 and associated proteins were precipitated with
anti-myc antibodies and fractionated onto an 8% SDS-PAGE
gel. p52 was detected with anti-HA antibody on a Western
blot (Figure 8A). Dimers of p66-p52 were found even when
cells were not treated, and H2O2 treatment modestly en-
hanced this dimerization. Similar results were obtained for
p66-p46 interaction (Figure 8B). Because p66 and p52/46
have different functions in ERK activation, increased dimer
formation between p66shcA and p52shcA or p46shcA in
response to H2O2 may help the cells to attenuate signal
transmission. This is consistent with our findings that ty-
rosine phosphorylation of p52 and p46 precedes Ser36 phos-
phorylation of p66.
Finally we determined whether interaction between
p66shcA and p52/46shcA exists between endogenous ShcA
proteins. We utilized antibodies that only recognize
p66shcA but not p52/46shcA for this purpose. Theoretically,
if ShcA proteins interact in vivo, immunoprecipitated
p66shcA should be able to bring down p52/46shcA. Cells
were treated with H2O2 to test whether association among
ShcA proteins would be enhanced under this condition. To
our expectation, both p52shcA and p46shcA were found to
associate with p66shcA. H2O2 stimulation slightly enhanced
the complex formation (Figure 8C). Because both p52shcA
and p46shcA run close to the immunoglobin heavy chain
that could be recognized in a nonspecific manner by anti-
ShcA antibodies (or secondary anti-rabbit antibodies), the
blot was also probed with anti-phospho-tyrosine antibodies
to pinpoint p52 and p46, which were tyrosine-phosphory-
lated in H2O2-treated cells. The results show that endoge-
nous ShcA proteins do exist in the cells as a complex.
Whether the complexes are in the form of dimer (homo or
hetero) or trimer needs further investigation.
DISCUSSION
We provide evidence to support that p66shcA is a cytoplas-
mic substrate for ERKs in response to H2O2 or serum stim-
ulation. Although previous studies have shown that inhibi-
tion of ERK activation inhibited the slower migration of
p66shcA in response to endothelin-1 (Foschi et al., 2001), our
results demonstrated for the first time that p66shcA (Ser36)
is a substrate of ERKs. p66shcA has a perfect MAPK recog-
nition motif (Ser36-Pro37) in the CH2 domain. We demon-
strated that p66shcA and ERK do interact in vitro and in
Figure 7. Interaction between p52 and p46
proteins. (A) GST-p52shcA was able to pull
down p46shcA. p46shcA expressed in COS7
cells were incubated with GST-p52shcA
beads overnight at 4°C. The beads were
washed and p46shcA was detected on a
Western blot. (B) GST-p46 was able to pull
down both p52shcA and p46shcA. p52shcA
and p46shcA (expressed from one mRNA)
expressed in COS7 cells were incubated with
GST-p46shcA beads overnight at 4°C. The
beads were washed and p46shcA and
p52shcA was detected by Western blot. (C)
p52shcA was able to precipitate coexpressed
p46shcA. COS7 cells were transfected with
p52shcA (flag-tagged at C terminus) and
p46shcA (HA tagged) and treated with H2O2
for 10 min. The cell lysates were incubated
with anti-Flag antibodies and p46 was de-
tected with anti-HA antibodies by Western
blot. (D) p46shcA was able to precipitate the
coexpressed p52shcA and p46shcA. The ex-
periments were carried out as in C, except
that the lysates were incubated with anti-HA
antibodies and the Western blot was probed
with anti-Flag antibodies.
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vivo. In vitro kinase assays confirmed that H2O2-activated
ERKs phosphorylated p66shcA with Ser36 being a major
site. Furthermore, ERK activation is necessary and sufficient
for H2O2-induced Ser36 phosphorylation. This conclusion is
further supported by the findings that inhibition of ERK
activation also impeded p66shcA downstream signaling
molecules such as Akt and downstream transcription factor
FOXO3a in a signaling pathway triggered by H2O2 (Nemoto
and Finkel, 2002). Even though serum feeding also resulted
in Ser36 phosphorylation in an ERK-dependent manner,
inhibition of ERKs, and therefore inhibition of p66shcA
phosphorylation, did not affect Akt activation or FOXO3a
phosphorylation induced by serum stimulation, suggesting
that the p66shcA-Akt-FOXO3a pathway is specific to H2O2,
but not to growth factors. One possible explanation is that
serum-induced Akt activation is mainly through RTK-PI-3
kinase pathway, whereas H2O2-induced Akt activation is
mainly through p66shcA.
What cellular events does the p66shcA-Akt-FOXO path-
way regulate in response to oxidative stress? Reactive oxy-
gen species have been documented to have a proapoptotic
role and under certain conditions, a mitogenic role. Mean-
while, ROS can also activate the antioxidant defense system
to protect the cells. Accumulating evidence suggests that
some of these effects of ROS are mediated by the FOXO
transcription factors, which are known to control cell cycle,
cell death, and stress detoxification by regulating transcrip-
tion of different sets of genes under various conditions (Tran
et al., 2003). For example, H2O2 has been reported to down-
regulate genes involved in both H2O2 scavenging and oxi-
dative stress resistance, e.g., catalase and MnSOD, by inac-
tivating FOXO3a through the p66shcA-Akt pathway
(Nemoto and Finkel, 2002; Trinei et al., 2002). In the absence
of p66shcA, this pathway is disrupted and as a consequence,
expression of these antioxidant proteins is maintained and
p66shcA-deficient cells exhibit resistance to oxidative stress
(Migliaccio et al., 1999; Nemoto and Finkel, 2002; Trinei et al.,
2002). In this regard, the action of the p66shcA-Akt-FOXO
pathway is to transduce proapoptotic signals. In contrast,
FOXO proteins also control expression of genes involved in
apoptotic induction such as Fas ligand and the Bcl2 family
member Bim. Activation of Akt and phosphorylation of
FOXO would lead to down-regulation of these two proteins,
facilitating cell survival. Furthermore, activation of Akt, a
well-studied mediator of survival, can lead to inactivation of
caspase 9 and the proapoptotic Bcl2 family member Bad, in
a transcription-independent manner. It appears that the Akt-
FOXO pathway also transduces antiapoptotic signals. In
addition, oxidative stress also activates many other signal-
ing pathways, including the protein kinase C (PKC) -Nrf2
pathway, which up-regulates the levels of antioxidant pro-
teins such as peroxiredoxin I, promoting cell survival (Li et
al., 2002, 2004). Therefore, all these signals would be inte-
grated to influence the decision making as to cell death or
survival in response to oxidative stress.
We discovered that p27kip1, a well-studied target gene of
FOXO3a, was down-regulated by H2O2, in correlation to
inactivation of FOXO3a. Furthermore, H2O2-induced Ser36
phosphorylation, Akt activation, as well as down-regulation
of p27 could be suppressed by inhibition of ERK activation.
This is the first time that a connection between oxidative
stress and p27 expression was established. What is the bio-
logical significance of reduced expression of p27 in response
to oxidative stress? p27 is a CDK inhibitor and is a negative
regulator of cell cycle progression. The levels of p27 are
decreased in many human cancers and growth factor–stimu-
lated cell proliferation is associated with down-regulation of
p27. In addition, previous studies showed that ectopic ex-
pression of activated FOXO3a led to cell cycle arrest in
which induction of p27 through FOXO3a appeared to play
an important role (Medema et al., 2000). We propose that
H2O2-induced down-regulation of p27 may facilitate cell
cycle entry, consistent with the finding that ROS can have a
mitogenic role under certain conditions (Li et al., 1997; Reth,
2002) and the recent finding that p66shcA is actually a
negative regulator of cell cycle progression (Pacini et al.,
2004). Yet, H2O2 alone was not sufficient to promote cells to
enter cell cycle, because we could not detect a marked in-
crease in proliferating cells under stimulation of a low dose
of H2O2. However, we could not exclude the possibility that
H2O2-induced p27 reduction may facilitate cell cycle pro-
gression under proper conditions, for example, when apo-
ptosis is blocked or other mitogenic signals are provided.
Recent studies also suggest that p27 may participate in
Figure 8. Interaction between p66shcA and
p46/52shcA. (A) H2O2 promoted association
between p66shcA and p52shcA. Immunopre-
cipitation assays were done as in C. (B) H2O2
promoted association between p66shcA and
p46shcA. Immunoprecipitation was carried
out as described in Figure 7C. (C) Endoge-
nous p66shcA was able to precipitate endog-
enous p52shcA and p46shcA in a co-IP exper-
iment. Cells were treated with H2O2 for 10
min and the cell lysates were incubated with
anti-p66shcA antibodies. The Western blot
was probed with anti-phospho-tyrosine and
anti-ShcA antibodies, respectively. Rabbit
IgG was used as a control for co-IP assays.
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apoptosis. Overexpression of p27 induces apoptosis in sev-
eral cell types and p27 deficiency protects cells from stress-
induced apoptosis, indicating a proapoptotic role for p27
(Dijkers et al., 2000). In contrast, there are also reports sug-
gesting an antiapoptotic role for p27 (reviewed in Coqueret,
2003). It appears that p27 can have different functions in
apoptosis, dependent on the cell types and stress types
(Coqueret, 2003). Studies of p27/ MEFs in comparison to
wild-type control cells revealed that p27 has a proapoptotic
role in response to oxidative stress, as p27/ MEFs showed
improved survival against H2O2. Therefore, H2O2-induced
down-regulation of p27 may provide a protective mecha-
nism in oxidative stress response. The modest effect of p27
supports the concept that the end result of oxidative stress is
determined by a coordinated action of various pathways.
Taken together, we found that H2O2 led to down-regulation
of p27, which may participate in cell response to oxidative
stress.
Our studies provided evidence that p52/46shcA are also
involved in oxidative stress response. They participated in
H2O2-induced activation of ERKs. It has long been known
that H2O2 activates ERK but the molecular mechanisms are
less clear. We found that oxidative stress led to phosphory-
lation of ShcA proteins on all three tyrosine residues (239/
240/371), the complex formation between ShcA and Grb2,
and activation of ERK. Mutant p52shcA (Y239/240/371 to
Phe) inhibited H2O2-induced ERK activation, and cells de-
ficient for ShcA showed diminished ERK activation. Thus,
H2O2-induced activation of ERKs follows the same pathway
triggered by growth factors. The question remains as to
what are the tyrosine kinases activated by H2O2 and capable
of phosphorylating ShcA proteins at all three residues. Al-
though previous studies have shown that H2O2 treatment
activates growth factor receptors such as EGFR and PDGFR,
probably by suppressing protein tyrosine phosphatases
(Knebel et al., 1996; Kamata and Hirata, 1999), PDGFR was
found unnecessary for ShcA phosphorylation or ERK acti-
vation. Other mechanisms have also been suggested by
which H2O2 activates ERK in different settings (Guyton et al.,
1996). Studies in cardiomyocyte showed that H2O2 directly
targeted Gi and Go, which led to dissociation of G and
subsequent activation of ERK (Nishida et al., 2000). In these
cells, activation of ERK required Src activation (Nishida et
al., 2000), but we found that deficiency of Src did not affect
phosphorylation of ShcA on tyrosine residues, Akt activa-
tion, or ERK1/2 activation induced by H2O2 in fibroblasts.
The discrepancy could be due to the ways by which Src is
inhibited. In previous studies, either an inhibitor or a dom-
inant negative form of Src was used, whereas in our studies,
Src/ MEFs were used. It is possible that dominant nega-
tive Src may interfere with the function of Src homologues
such as Yes and Lyn.
Our findings also suggest that p66shcA played a negative
role in H2O2-induced ERK activation, in which Ser36 phos-
phorylation is critical, because mutant p66shcA (S36A)
showed some stimulatory effect. A negative role for p66shcA
ERK activation has been previously reported in response to
growth factor (Migliaccio et al., 1997; Okada et al., 1997).
Hence, all the three ShcA isoforms participate in p66shcA
phosphorylation: p52/46shcA facilitates ERK activation; ac-
tivated ERK in turn phosphorylates p66shcA, leading to
FOXO3a phosphorylation. Therefore, in this event, they
functioned in a cooperative way. Later, the Ser36-phosphor-
ylated p66shcA may block ERK activation as a feedback
regulation. In this regard, ShcA proteins clearly have distinct
functions. What is the molecular basis for the isoform spe-
cific effects? How do ShcA isoforms achieve their functions?
We believe that our studies may provide some hints to the
above questions. We found that ShcA isoforms interact with
each other and may exist as dimers or multimers in the cell.
H2O2 treatment promotes the association between p66shcA
and p52shcA or p46shcA, but not between p52 and p46.
Because p52shcA and p46shcA are more abundant than
p66shcA in fibroblasts, they may exist as dimers in the cell
and facilitate ERK activation in response to H2O2. The
switch to p66-p52 or p66-p46 may act to interfere with
p52/46shcA function and thereby attenuate ERK activation.
In accordance with this, it was found that ectopic expression
of p66shcA in ShcA/ MEFs did not inhibit ERK activation
(Hu and Li, unpublished data), suggesting that the inhibi-
tory effect of p66shcA on ERK activation was via p52/
46ShcA. Alternatively, it is possible that the interaction
among ShcA isoforms may help to assemble upstream and
downstream components, e.g., protein phosphatase 2A,
MAPKAP kinase2, SHIP, Grb2 (all interact with ShcA), into
an organized signaling complex, enhancing the efficiency of
signaling propagation (Lamkin et al., 1997; Ugi et al., 2002;
Yannoni et al., 2004). In this regard, the complex may act as
an anchoring scaffold to facilitate signal transmission (Bu-
rack and Shaw, 2000). Certainly, the exact function of the
complex formation among ShcA proteins warrants further
investigation.
The major finding of this study is that phosphorylation of
p66shcA on Ser36 serves two purposes in cell response to
oxidative stress: transmitting signals to modulate p27 ex-
pression to influence cell response to oxidative stress; and
inhibiting ERK activation through a negative feedback
mechanism. In response to H2O2, all three ShcA proteins
participate in transmitting signals to inactivate transcription
factor FOXO3a, in two steps: H2O2 first induces phosphor-
ylation of tyrosine residues of ShcA proteins, facilitating
ERK activation; and activated ERKs in turn phosphorylate
p66shcA on Ser36, leading to phosphorylation of FOXO3a
by Akt and down-regulation of p27. p66shcA may inhibit
ERK activation by forming complexes with p52shcA or
p46shcA, the stimulatory ShcA proteins for ERK activation.
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